Literature DB >> 2581852

Analysis of the antigenic composition of liver specific lipoprotein using murine monoclonal antibodies.

K H Wiedmann, L K Trejdosiewicz, A H Goodall, H C Thomas.   

Abstract

Eight monoclonal antibodies have been raised to antigenic determinants within the liver specific lipoprotein complex. Five of these determinants were species and the others non-species specific. No liver specific determinants were identified. Liver specific lipoprotein antigens recognised by the eight monoclonal antibodies were located either on the hepatocyte membrane and/or along the sinusoidal lining wall or in the cytoplasm of liver parenchymal cells. All antibodies but one reacted with the cell membrane of viable human hepatocytes. The molecular weights of four liver specific lipoprotein-determinants were determined by immunoprecipitation. These ranged from 22 000 to 164 000 daltons.

Entities:  

Mesh:

Substances:

Year:  1985        PMID: 2581852      PMCID: PMC1432664          DOI: 10.1136/gut.26.5.510

Source DB:  PubMed          Journal:  Gut        ISSN: 0017-5749            Impact factor:   23.059


  18 in total

1.  Detection of a liver-membrane autoantibody in HBsAg-negative chronic active hepatitis.

Authors:  U Hopf; K H Meyer zum Büschenfelde; W Arnold
Journal:  N Engl J Med       Date:  1976-03-11       Impact factor: 91.245

2.  Protein measurement with the Folin phenol reagent.

Authors:  O H LOWRY; N J ROSEBROUGH; A L FARR; R J RANDALL
Journal:  J Biol Chem       Date:  1951-11       Impact factor: 5.157

3.  Inadequate antibody response to hBAg or suppressor T-cell defect in development of active chronic hepatitis.

Authors:  A L Eddleston; R Williams
Journal:  Lancet       Date:  1974-12-28       Impact factor: 79.321

4.  Liver-specific antigens of different species. II. Localization of a membrane antigen at cell surface of isolated hepatocytes.

Authors:  U Hopf; K H Meyer zum Büschenfelde; J Freudenberg
Journal:  Clin Exp Immunol       Date:  1974-01       Impact factor: 4.330

5.  Liver specific antigens. Purification and characterization.

Authors:  P A Miescher
Journal:  Clin Exp Immunol       Date:  1972-01       Impact factor: 4.330

6.  Purification and characterization of human liver-specific membrane lipoprotein (LSP).

Authors:  I G McFarlane; B M Wojcicka; G M Zucker; A L Eddleston; R Williams
Journal:  Clin Exp Immunol       Date:  1977-03       Impact factor: 4.330

7.  Detection of antibodies directed against a liver-specific membrane lipoprotein in patients with acute and chronic active hepatitis.

Authors:  D M Jensen; I G McFarlane; B S Portmann; A L Eddleston; R Williams
Journal:  N Engl J Med       Date:  1978-07-06       Impact factor: 91.245

8.  Establishment of a continuously growing cell line from primary carcinoma of the liver.

Authors:  J J Alexander; E M Bey; E W Geddes; G Lecatsas
Journal:  S Afr Med J       Date:  1976-12-18

9.  Cell-mediated immunity to human Tamm-Horsfall glycoprotein in autoimmune liver disease with renal tubular acidosis.

Authors:  D C Tsantoulas; I G McFarlane; B Portmann; A L Eddleston; R Williams
Journal:  Br Med J       Date:  1974-11-30

10.  Protein and cell membrane iodinations with a sparingly soluble chloroamide, 1,3,4,6-tetrachloro-3a,6a-diphrenylglycoluril.

Authors:  P J Fraker; J C Speck
Journal:  Biochem Biophys Res Commun       Date:  1978-02-28       Impact factor: 3.575

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.